" The information the others don't give you." No drug company funding or influence!
The MedicationSense E-Newsletter 2008
A REPORT OF MAJOR IMPROVEMENT IN A CASE OF FLUOROQUINOLONE TOXICITY. A man reports 95 percent improvement after finding an effective treatment 3 years after a severe reaction with Avelox (moxifloxacin).
TIM RUSSERT: WOULD FISH OILS HAVE SAVED HIS LIFE?
When Russert, the political commentator, died suddenly at the age of 58 earlier this month, people were surprised. Unfortunately, there is nothing surprising about sudden cardiac death.
WHY SOME GENERIC DRUGS DO NOT WORK. A Rare Interview with Joe and Teresa Graedon of The People’s Pharmacy.
STATIN SIDE EFFECTS: DO DOCTORS TAKE PATIENTS' COMPLAINTS SERIOUSLY? A New Study Reveals What Happens When Patients Complain of Statin Side Effects to Doctors.
The MedicationSense E-Newsletter 2007
STATIN DRUGS, LIVER INJURY, AND CANCER: IS THERE A CONNECTION?
A New Study Provides Additional Reasons to Avoid High Doses of Statin Medications.
MORE DOCTORS AND MEDICAL CENTERS ARE GOING "PHARM-FREE". Choosing Ethics over Drug-Company Enticements. Medical Students a Force. Will Others Follow?
PUSHING HIGH-DOSE LIPITOR: MEDICAL SCIENCE OR SLICK MARKETING? Thousands of Drug Sales Reps Are Influencing Doctors to Prescribe High-Dose Lipitor despite Ongoing Concerns about Efficacy and Safety. Does the Pharmaceutical Industry Place Sales over Safety?
The MedicationSense E-Newsletter July - December, 2006
HIGH-DOSE LIPITOR FOR STROKES: HOW EFFECTIVE, HOW SAFE?
A new study of high-dose Lipitor for people with strokes reveals minimal benefit and unanswered questions about safety. Yet doctors are prescribing high-dose Lipitor to more patients.
HIGH-DOSE LIPITOR FOR HEART ATTACKS: HOW EFFECTIVE, HOW SAFE?
A New Study Shows the Maximum-Dose Lipitor Reduces Heart Attacks, but Other Findings Raise Serious Safety Concerns. Dr. Cohen Explains Who Should Use High-Dose Lipitor -- and Who Should Not.
A PREVENTIVE FOR ALZHEIMER'S DISEASE? - October, 2006 
Another Powerful Study Shows A Markedly Reduced Risk of Alzheimer's with Fish Oils (Omega-3 Oils). Natural Substances or Prescription Drugs for Alzheimer's Disease?
THE
MEDICAL PROFESSION AND THE CULTURE OF CORRUPTION, PART 2:
From Lancet: "Just How Tainted Has
Medicine Become?"
Another top Medical Journal
asks a tough question about doctors-drug industry conflicts of interest.
The MedicationSense E-Newsletter January -June, 2006
THE MEDICAL PROFESSION
AND THE CULTURE OF CORRUPTION,
PART 1:
Respected Physicians Call for End of Conflicts
of Interest with Drug Industry.
LOW-FAT DIETS DON'T WORK? DON'T BELIEVE IT! Sensationalistic Newspaper Headlines Misrepresent Three Major, Yet Flawed Studies. Here is What the Studies Actually Found.
The MedicationSense E-Newsletter July - December, 2005
CRESTOR SIDE EFFECTS MAKE MORE HEADLINES -- BUT UNDERLYING CAUSES AND PREVENTIVE MEASURES ARE AGAIN IGNORED. A New Study Shows Higher Rates of Adverse Reactions with Crestor Than with Other Statins. Here's the Real Story on Super-Strong Crestor and What to Do About It.
NEW WARNINGS FOR CIPRO, LEVAQUIN, AND OTHER QUINOLONE ANTIBIOTICS. Serious Reactions Continue to Be Reported. This article is an updated version of my original article on reactions with fluoroquinolone antibiotics that I posted in the July-Sept. 2003 newsletter
The MedicationSense E-Newsletter January - June, 2005
CREDO Medication side effects are the #4 leading cause of death in the U.S. annually (JAMA 1998). Yet, few people receive informed consent about prescription drugs. This website is dedicated to providing objective information to help you and your doctor make informed, intelligent choices about medications and effective alternatives to enable you to maximize the benefits while minimizing the risks of treatment. |
BEXTRA: DESIGNED BY PFIZER
TO FAIL.
An Open
Letter to Pfizer Inc. on the Underlying Reasons That Bextra Failed,
on Why Pfizer Made Bextra Unnecessarily Risky -- and on How Pfizer
Might Still Save Celebrex.
Celebrex
and Bextra: A better way to make these
drugs safer.
FDA
Advisory Committee Finds COX-2 Drugs Increase Risks of Heart
Attacks and Strokes, Advises Stronger Warnings -- But Does Not
Require Manufacturer to Market Lower, Safer, Proven-Effective
Doses.
The MedicationSense E-Newsletter Oct. - Dec., 2004
What
Now for Users of Vioxx, Celebrex, and Bextra?
How to Use Anti-Inflammatory
Drugs (NSAIDs) More Safely -- and Natural Alternatives That Work.
FLASH! Available in the new, October issue of the Annals of Pharmacotherapy,
Dr. Cohen's new article: Antidepressants--An Avoidable and Solvable
Controversy. Click
Here to Read.
Why
Antidepressant Black-Box Warnings Aren't Enough -- What Doctors and
Patients Can Do to Use Antidepressants Safely. A
FDA Advisory Committee Recommendation for Stronger Warnings Is a
Step Forward, but Not a Solution. What
We Must Do.
Workplace
Stress, Depression, And The Overuse of Antidepressant Drugs In The
Workplace:
An
Interview with Dr. Richard Lippin, an Expert on Occupational and Environmental
Medicine.
The
Truth About Crestor: Is Crestor Dangerous And If So, Why?
The
intensive marketing of this new, super-strong, cholesterol-lowering statin drug
raises questions and concerns. Are Crestor users in jeopardy? is Crestor especially
dangerous for Asians? Who should take Crestor and when? A lower, safer approach
that most doctors and patients don't know about.
The MedicationSense E-Newsletter Apr. - Jun., 2004
Patients
Regain the Right to Control Their Own Medications.
Your Consent Is Now Required before Your Medications Can Be Switched. The Nation's
Largest Pharmacy-Benefit Manager Agrees to Settle.
How a dysfunctional medical-pharmaceutical complex causes and perpetuates unnecessary harm.
After Finally Issuing Warnings 16 Years Late, British and U.S. Authorities Fail to Tell Doctors and Patients How to Actually Prevent Serious Side Effects, Leaving Millions at Further Risk. What Should Be Done?
DR. Cohen Debates The FDA: March 26, 2004
In their fourth debate in two years, Dr. Cohen and Dr. Robert Temple, the FDA's top medication expert and its Assistant Director for the FDA Center for Drug Evaluation and Research, squared off at the Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
INTERVIEW: Duane Graveline Medical Doctor, Astronaut, and Critic of Lipitor and Other Cholesterol-Lowering Statin Drugs.
Interview with Bill Faloon of the Life Extension Foundation:
A Recent Clash with the FDA Places the Spotlight on the Largest Anti-Aging, Research and Supplement Organization in the U.S. Is Life Extension Possible? Where Does Anti-Aging Stand Today?
An
Open Letter to the U.S. Food and Drug Administration on Serotonin-Enhancing
Antidepressants in Youngsters: A 6-Point Solution That Makes
Sense Scientifically.
There is a reason
that serotonin-enhancing antidepressants are repeatedly linked to
suicides and homicides, and there is a solution to this problem.
Antidepressant
Side Effects: In a New York Times Exposé,
A Doctor Describes Her Own Reaction to an Antidepressant Drug. But She
Doesn't Explain Why Antidepressant Side Effects Occur and How to Prevent
Them. This Article Does.
"How
Low Should Cholesterol Lowering Go?"
While New Studies Encourage the Aggressive Use
of Statins, Patients Continue to Balk. Why? Does Mainstream Medicine
Downplay Statin Side Effect? Is Lipitor Really Better Than Pravachol
-- and for Whom?
An
Open Letter To Congressman Holt on Severe, Disabling Reactions Linked to
Cipro, Levaquin, and Other Fluoroquinolone Antibiotics.
Why hasn't the FDA acted
on the hundreds, perhaps thousands of serious, disabling reactions linked
to these drugs? Most cases involve young, previously healthy people with
minor sinus, bladder, or prostate infections, for which doctors could prescribe
other, safer, cheaper drugs.
PRILOSEC
OTC -- How Does It Compare to Zantac 75, Pepcid AC, and Other Over-The-Counter
Heartburn Remedies? When To Use Prilosec OTC. What the Product
Label Doesn't Tell You. Special Risks for Seniors, Asians, Slow Metabolizers,
and the Medication-Sensitive?
Seniors,
Side Effects, and Celebrex: Does This Strong, One-Size-Fits-All
Drug Put Seniors, Women, And Others At Unnecessary Risk?
How Marketing Overrides Medical Science Once Again.
Suicides
and Homicides in Patients Taking Paxil, Prozac, and Zoloft:
Why They Keep Happening -- And Why They Will Continue.
Underlying Causes That Continue to Be Ignored by Mainstream Medicine and the
Media.
Omega-3
Oils Prevent Sudden Cardiac Death.
The Sudden Deaths of Sports
Heroes John Unitas, Dave DeBusschere, and Darryl Kyle Should Have Raised
Awareness That Most of the 250,000 Sudden Cardiac Deaths Annually Can Be
Prevented with Fish Oils. Why We Keep Missing the Message.
What
Now for Women Who Benefit from Hormone Replacement Therapy (HRT)? A
New Study and Condescending Headlines May Be Wrong.
How the System Discounts Patients, Especially Women.
AMA:
Switching Patients' Medication Without Their Consent is Unethical
Switching patients' drugs without their input occurs frequently
in health management systems today. But is it ethical? What about your
right of informed consent? I raised this issue in a top medical journal,
then asked the American Medical Association.
The
HRT (Hormone Replacement Therapy) Debacle and What it Says
About Drug Safety in America
New studies link the hormones in Prempro and Premarin
with cancer and heart disease, shocking millions of women and their
doctors. But why were three generations of women exposed before discovering
these risks? Is the problem the drugs or excessive doses? So many questions
haven't been answered, especially this one: What does the HRT debacle
say about drug safety today?
Serious
Reactions Associated with Cipro, Levaquin, and Related Antibiotics
Since the publication of my article on Cipro's
side effects during the anthrax scare of September 2001, I continue
to receive reports of devastating reactions linked to Cipro, Levaquin,
and other fluoroquinolone antibiotics. My article prompted the U.S.
Centers for Disease Control to alter their guidelines, but it hasn't
altered the overuse of these antibiotics and the failure of the healthcare
system to prevent these problems.
Cohen, Nader, Rosenfeld, Kelly Address Drug Company Leaders
Prescription
Drug Use in America: The Startling Numbers and Their Implications
In 2002, Americans filled 3,340,000,000 outpatient
prescriptions -- 12 prescriptions for every man, woman, and child.
Is today's American dream 2 kids, 2 cars, and a dozen drugs for everyone?
Medications are vital for millions of people, but what is the message:
that for every symptom and sensation the solution is a pill?
Chocolate:
A Health Food?
Can we believe a recent study revealing the benefits
of chocolate? And the enthusiasm of doctors, mainstream and alternative,
including Andrew Weil? Or is it too good to be true? And how much chocolate
can we enjoy?
Copyright 2008, Jay S. Cohen, M.D. All rights reserved.
Site
created and managed by Warwick
Graphics.
If you notice any problems with this site please notify webmaster by clicking here.
